Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C motif chemokine ligand 5 (CCL5), also known as RANTES, is a member of the CC chemokine family. It plays a crucial role in recruiting immune cells to sites of inflammation and is implicated in various diseases, including cancer, cardiovascular disorders, and HIV infection. CCL5 primarily binds to the CCR5 receptor, activating downstream signaling pathways involved in immune responses and inflammation. Its interaction with CCR5 can be targeted therapeutically, as exemplified by the use of maraviroc as a CCR5 antagonist for HIV treatment.
CCR5 antagonist
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C Motif Chemokine Ligand 5 (CCL5).